Pharmacological prevention of PPAR‐α downregulation shows potential since inhibition of JNK restored PPAR‐α protein levels and was enough to prevent myocardial dysfunction after infection(Drosatos et al, 2011; Drosatos & Schulze, 2013). The gene discussed is PPARA; the disease is infection.